Scientific Papers
Article
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Big study reveals increased heart disease and diabetes risk after COVID-19
Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
The role of immune responses to previously seen endemic coronavirus epitopes in severe acute respiratory coronavirus 2 (SARS-CoV-2) infection and disease progression has not yet been determined.
Scientific Papers
Article
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge model
In this human infection challenge pilot study, adults aged 18–55 years and 60–75 years were assessed for enrolment using protocol-defined inclusion and exclusion criteria.
New study: People with Diabetes are at Increased Risk of Flu Complications
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above.
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals.
Using correlates to accelerate vaccinology
Correlates and surrogates of desired outcomes are valuable but have limitations
Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial
